Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis

被引:11
|
作者
Yamamoto, Kei [1 ,2 ]
Sato, Takao [1 ,2 ]
Salem, Hanan [1 ,2 ,3 ]
Matsumura, Mitsuaki [2 ]
Fall, Khady N. [1 ]
Prasad, Megha [1 ]
Ng, Vivian G. [1 ]
Sethi, Sanjum S. [1 ]
Nazif, Tamim M. [1 ,2 ]
Parikh, Sahil A. [1 ,2 ]
Vahl, Torsten P. [1 ,2 ]
Ali, Ziad A. [2 ,4 ]
Karmpaliotis, Dimitri [2 ,5 ]
Rabbani, LeRoy E. [1 ,2 ]
Collins, Michael B. [1 ,2 ]
Leon, Martin B. [1 ,2 ]
Mcentegart, Margaret [1 ,2 ]
Moses, Jeffery W. [1 ,2 ]
Kirtane, Ajay J. [1 ,2 ]
Mintz, Gary S. [2 ]
Maehara, Akiko [1 ,2 ,6 ]
机构
[1] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY USA
[2] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA
[3] Tanta Univ, Cardiovasc Med Dept, Fac Med, Tanta, Egypt
[4] St Francis Hosp, Roslyn, NY USA
[5] Morristown Med Ctr, Gagnon Cardiovasc Inst, Morristown, NJ USA
[6] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 1700 Broadway,9th Floor, New York, NY 10019 USA
关键词
in-stent restenosis; intravascular ultrasound; PCI; DRUG-ELUTING STENTS; 2-YEAR FOLLOW-UP; BALLOON ANGIOPLASTY; IMPLANTATION; PREDICTORS; FRACTURE; INSIGHTS;
D O I
10.4244/EIJ-D-23-00107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite a high rate of in-stent restenosis (ISR) after stenting the right coronary artery (RCA) ostium, the mechanism of ostial RCA ISR is not well understood.Aims: We aimed to clarify the cause of ostial RCA ISR using intravascular ultrasound (IVUS).Methods: Overall, 139 ostial RCA ISR lesions were identified with IVUS, pre-revascularisation. Primary ISR mechanisms were classified as follows: 1) neointimal hyperplasia (NIH); 2) neoatherosclerosis; 3) ostium not covered by the stent; 4) stent fracture or deformation; 5) stent underexpansion (old minimum stent area <4.0 mm2 or stent expansion <50%); or 6) a protruding calcified nodule.Results: The median duration from prior stenting was 1.2 (first quartile 0.6, third quartile 3.1) years. The primary mechanisms of ISR were NIH in 25% (n=35) of lesions, neoatherosclerosis in 22% (n=30), uncov-ered ostium in 6% (n=9) (biological cause 53%, n=74), stent fracture or deformation in 25% (n=35), under -expansion in 11% (n=15), and protruding calcified nodules in 11% (n=15) (mechanical cause 47%, n=65). Including secondary mechanisms, 51% (n=71) of ostial RCA ISRs had stent fractures that were associated with greater hinge motion of the ostial-aorta angle during the cardiac cycle. The Kaplan-Meier rate of target lesion failure at 1 year was 11.5%. When the mechanically caused ISRs were treated without new stents, they suffered a higher subsequent event rate (41.4%) compared with non-mechanical causes or mechanical causes treated without restenting (7.8%, unadjusted hazard ratio 6.44, 95% confidence interval: 2.33-17.78; p<0.0001).Conclusions: Half of the ostial RCA ISRs were due to mechanical causes. Subsequent event rates were high, especially in mechanically caused ISRs treated without the implantation of a new stent.
引用
收藏
页码:E383 / +
页数:25
相关论文
共 50 条
  • [41] Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons
    Secco, Gioel Gabrio
    Foin, Nicolas
    Viceconte, Nicola
    Borgia, Francesco
    De Luca, Giuseppe
    Di Mario, Carlo
    EUROINTERVENTION, 2011, 7 (07) : 828 - 834
  • [42] Outcomes Following Treatment of Femoropopliteal In-Stent Restenosis: A Single Center Experience
    Yeo, Khung-Keong
    Malik, Umer
    Laird, John R.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 78 (04) : 604 - 608
  • [43] Impact of intracoronary radiation on in-stent restenosis involving ostial lesions
    Ajani, AE
    Waksman, R
    Cheneau, E
    Leborgne, L
    Pinnow, E
    Canos, DA
    Satler, LF
    Pichard, AD
    Kent, KM
    Lindsay, J
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 58 (02) : 175 - 180
  • [44] Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
    Joo, Hyung Joon
    Jeong, Han Saem
    Kook, Hyungdon
    Lee, Seung Hun
    Park, Jae Hyoung
    Hong, Soon Jun
    Yu, Cheol Woong
    Lim, Do-Sum
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [45] Characterization and Clinical Outcomes of Drug-Eluting In-Stent Restenosis
    Vaknin-Assa, Hana
    Assail, Abid
    Lev, Eli
    Ben-Dor, Itzik
    Brosh, David
    Teplitsky, Igal
    Kornowski, Ran
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2010, 12 (05): : 273 - 276
  • [46] Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach
    Waksman, Ron
    Iantorno, Micaela
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (12)
  • [47] Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach
    Ron Waksman
    Micaela Iantorno
    Current Cardiology Reports, 2018, 20
  • [48] In-stent restenosis caused by a reprotruding calcified nodule and stent fracture in the hinged coronary artery
    Murakami, Tsukasa
    Kojima, Keisuke
    Jinnouchi, Hiroyuki
    Takenoya, Masanori
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 104 (03) : 511 - 515
  • [49] Intravascular lithotripsy for the treatment of inferior mesenteric artery in-stent restenosis
    Ratner, Molly
    Muqri, Furqan
    Garg, Karan
    JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES, 2023, 9 (03):
  • [50] In-Stent Restenosis in the Superficial Femoral Artery
    Razzouk, Louai
    Aggarwal, Saurabh
    Gorgani, Farzan
    Babaev, Anvar
    ANNALS OF VASCULAR SURGERY, 2013, 27 (04) : 510 - 524